Metallomics in pulmonary arterial hypertension patients
Abstract Pulmonary arterial hypertension (PAH) prevalence is increasing worldwide, and the prognosis is poor with 5‐year survival < 50% in high risk patients. The relationship between metal exposure/essential metal dyshomeostasis and PAH/right ventricular dysfunction is less investigated. The aim...
Main Authors: | Karim El‐Kersh, C. Danielle Hopkins, Xiaoyong Wu, Shesh N. Rai, Matthew C. Cave, M. Ryan Smith, Young‐Mi Go, Dean P. Jones, Lu Cai, Jiapeng Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Pulmonary Circulation |
Subjects: | |
Online Access: | https://doi.org/10.1002/pul2.12202 |
Similar Items
-
Plasma level of antimony correlates with pulmonary arterial hypertension severity
by: Karim El-Kersh, et al.
Published: (2022-01-01) -
Pulmonary artery vasodilators for treatment of pulmonary hypertension complicating fibrosing mediastinitis
by: Daniel Van Kalsbeek, et al.
Published: (2024-01-01) -
Identification of biomarkers related to copper metabolism in patients with pulmonary arterial hypertension
by: Lei Wang, et al.
Published: (2023-01-01) -
Experimental Schistosoma haematobium pulmonary hypertension
by: Biruk Kassa, et al.
Published: (2024-01-01) -
Sarcoidosis-associated pulmonary hypertension
by: Kašiković-Lečić Svetlana, et al.
Published: (2022-01-01)